← Back to Search

Multidisciplinary Health Intervention for Blood Cancer

N/A

Waitlist Available

Led By Andrew S Artz

Research Sponsored by City of Hope Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Hematologic malignancy or disease as indication for HCT

>= 65 years at time of planned HCT infusion

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

Study Summary

This trial is studying a multidisciplinary intervention to help older adults with blood cancers who are planning a stem cell transplant. The intervention includes multiple healthcare professionals and is aimed at improving fitness and the ability to bounce back after transplant.

Who is the study for?

This trial is for older adults (65+) with blood cancers who are candidates for stem cell transplantation. Participants must be able to read English, Spanish, or Mandarin and consent to the study's requirements. Those with prior allogeneic transplants or conditions that make study procedures unsafe are excluded.Check my eligibility

What is being tested?

The trial is testing a multidisciplinary approach involving various healthcare professionals aimed at improving fitness and recovery post-transplant in older adults. It includes health promotion activities, quality-of-life assessments, and questionnaires.See study design

What are the potential side effects?

Since this trial focuses on non-medical interventions like health promotion and questionnaires rather than drugs or medical treatments, traditional side effects are not applicable. However, participants may experience fatigue or stress related to additional appointments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I need a stem cell transplant for my blood cancer.

Select...

I am 65 years or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of multidisciplinary team (MDT) (met 90 percent threshould, yes / no)

Secondary outcome measures

Dose intensity of resiliency bolstering

Functional independent survival (FIS)

Library of MDT-facilitated intervention

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (MDT-intervention)Experimental Treatment3 Interventions

Patients participate in the MDT-intervention including access to a HCT physician, a geriatrician, physical or occupational therapist, dietician, and a social worker for three months before HCT and up to 100 days after HCT.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor

565 Previous Clinical Trials

1,921,420 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,113 Total Patients Enrolled

1 Trials studying Blood Cancers

70 Patients Enrolled for Blood Cancers

Andrew S ArtzPrincipal InvestigatorCity of Hope Comprehensive Cancer Center

1 Previous Clinical Trials

164 Total Patients Enrolled

Media Library

Multidisciplinary Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04914338 — N/A

Blood Cancers Research Study Groups: Supportive care (MDT-intervention)

Blood Cancers Clinical Trial 2023: Multidisciplinary Intervention Highlights & Side Effects. Trial Name: NCT04914338 — N/A

Multidisciplinary Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04914338 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many test subjects are participating in this experiment?

"That is correct. According to the information shared on clinicaltrials.gov, this medical trial commenced recruiting patients on June 3rd 2021 and was last refreshed on August 15th 2022. Currently, 40 subjects are needed at 1 site."

Answered by AI

Is recruitment still in process for this research?

"This medical trial, which was initially shared on June 3rd 2021, is presently enrolling patients. The details for this study were last modified on August 15th 2022 according to clinicaltrials.gov ."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell Transplantation

2021. "A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell Transplantation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04914338.

All > Blood Cancer